KANSL2 and glioblastoma: KANSL2 was shown to drive the stem cell‐like features of glioblastoma cells, and knockdown of KANSL2 reduced expression of the pluripotency factors NANOG and POU5FI, while it increased the expression of the neural differentiation markers TUBB3 and GFAP95.